Navigation Links
Largest study of fertility patients shows concerns about embryo disposition
Date:12/3/2008

DURHAM, NC -- Fertility patients who are done having children feel responsible for the stored, frozen embryos left over from their treatment, yet more than half are against implanting the embryos in anyone else, according to a new study by researchers at Duke University Medical Center.

"This really turns our moral presumptions on their heads," says Anne Drapkin Lyerly, MD, an obstetrician/gynecologist and bioethicist at Duke, and lead investigator of the findings that appear online in Fertility & Sterility.

"Parents care very much about what happens to their embryos, but that doesn't mean they want them to become children. Our study shows that many feel they have to do what they can to prevent their embryo from becoming a child."

The survey of more than 1,000 fertility patients is the largest and only multi-site study to shed important light on the state of the nation's 500,000 frozen embryos currently in storage. It reveals previously unexplored concerns that patients have about their embryos, and it comes at a time when several states and even the federal government are attempting to enact legislation that would either assert an embryo is a person, allow abandoned embryos to be adopted by another couple, or allow unused embryos to become "wards of the state."

What to do with those unused embryos has also become a sticking point for providers, since they are held responsible for safe storage or disposition of apparently abandoned embryos.

Fresh embryos are used in more than 80% of fertility treatment cycles, but most patients also choose to freeze some embryos that were created but not implanted, to use as a possible backup. This means that extra embryos often remain after treatment is completed. Previous studies have found that when childbearing is complete, as many as 70 percent of patients put off for five years -- or more -- the decision of what to do with those frozen embryos, even while they continu
'/>"/>

Contact: Debbe Geiger
Debbe.Geiger@duke.edu
919-660-9461
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Courion Helps Reduce Costs at Nations Largest Operator of Senior Living Communities
2. Antibiotics Largest Cause of Drug-Induced Liver Damage
3. Kindred Healthcare, Nations Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management
4. Medical Technology to be Highlighted at World's Largest Simulation Exhibition
5. November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History
6. Military, Industry Leaders to Speak at World's Largest Simulation Event
7. World's Largest Modeling and Simulation Exhibition Sells Out for '08
8. Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
9. Jackson Healthcare Named 5th Largest Healthcare Staffing Company
10. Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World
11. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., SANTA CRUZ, CA--New connections begin to form b...earn a new task, according to a study published th...versity of California, Santa Cruz, the study invol...s that take place in the brain during motor learni...trained to reach through a slot to get a seed. The...
(Date:11/29/2009)...any doctors unaware the sleep disorder boosts urin...ov. 29 (HealthDay News) -- People who wake up duri...ame a urological problem. Sleep apnea, a breathing...A new study suggests that nighttime urination, or ...r for obstructive sleep apnea, a disorder in which...
(Date:11/28/2009)..., , CHICAGO, Nov. 28 Get...on practice in the clinical routine when Sieme...entific Assembly and Annual Meeting of the Radiolo...r 29 to December 3 at McCormick Place (Booth #825,.... With syngo. via , Siemens, new imaging s...
(Date:11/27/2009)..., , BEDFORD, Mass., Nov. 27 /PRNewswire-Fi...e "Company"), a supplier of precision technology p... that an annual meeting of the Company,s sharehold... The time and location of the meeting will be ann...e Company received a requisition notice from Steph...
(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-First... announced that Blair Lambert, CFO/COO, will prese...will be held at the May Fair Hotel in London, Engl... GMT. ,, To listen to a live broadcast of The G...et, please log on to www.gymboree.com, click on "O...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...Health Minister Dr Anbumani Ramadoss, in an attemp...ese Encephalitis has left for Beijing to approach ...able in a sizeable // quantity. The heavy toll of ...iled discussions with the Chinese minister for Nat...
...Doctors say they want to investigate the case of a...of the virus, reports BBC. // Two Sunday news...in London, was diagnosed as HIV-positive in 2002, ... tests. Stimpson did not take any medication for H...
...Study results showed that people who lived longer ... social position. The research study was carried o...d's School of Public Health who reported their fin...ildren’s with a score more than 130 are considered...
...John Cacioppo and researchers have found that the ...d it runs in to families making it a genetic chara...le should join a group which has more social chara...nd they found that loneliness is not related to he...
...A new study appearing in the November 1, 2005 issu...that a new gene profile may help in predicting how...nd to aggressive chemotherapy. // In many patie...nce of chemotherapy-resistant cancer cells, most p...
...In a breakthrough, which could eventually lead to ...he HIV virus, scientists from the US National Canc...ving in the human body to produce chemicals that b... bacteria. The researchers have successfully...
Other Medicine News:Health News:Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations 2Health News:British man 'Recovered from HIV' 2Health News:Genetic Profile To Predict Ovarian Cancer Prognosis 2Health News:Genetically modified bacteria to combat HIV 2
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 Heska Corporation ( HS...iagnostic and specialty products to the veterinary...iagnostics Corporation for the supply of blood gas...inary market. ,, (Logo: http://www.newscom...a and Roche share the same passion for innovating ...
(Date:11/25/2009)...wswire/ -- BioTrends Research Group, Inc. released...eport, the first in a multi-phase syndicated marke... Ortho-Biotech,s Stelara, from product launch thro...ve of the report provides quantitative information...ormation from a subset of 20. The reports assess ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 1FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 2FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 3FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 4Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 1Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 1Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 3Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 4Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 5Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 6
...y 21 Romark Laboratories, L.C., a,privately-owned...mpletion,of enrollment into its Phase II clinical ...oxanide in combination with standard of care thera...ype 1 who have previously,failed to respond to the...irin). The company expects to announce interim dat...
...rgentina, May 21 Today at the,World Congress of C...w,Perspectives in Atrial Fibrillation Management" ...ogy, St George,s University of London,highlighted ...cal trial,results, as the way forward in the futur...on form of cardiac arrhythmia., To view the Multi...
Other Medicine Technology:Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 2Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6
Maumenee tying forceps
Anis tying forceps
McPherson tying forceps
Harms-Tubingen Straight Tying Forceps
Medicine Products: